XENE
Xenon Pharmaceuticals Inc
NASDAQ: XENE · HEALTHCARE · BIOTECHNOLOGY
$55.75
+2.24% today
Updated 2026-04-29
Market cap
$5.39B
P/E ratio
—
P/S ratio
718.38x
EPS (TTM)
$-4.36
Dividend yield
—
52W range
$28 – $64
Volume
1.5M
WallStSmart proprietary scores
22
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F7.3
Quality
B+2.5
Profitability
F5.0
Valuation
C+3/9
Piotroski F-Score
Weak
8.4
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$79.24
+42.13%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
3 Strong Buy17 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Altman Z 8.38 — safe zone
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-81.80M
- Revenue declining -100.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $9.43M | $0.00 | $0.00 | $7.50M | $7.50M |
| Net income | $-125.37M | $-182.39M | $-234.33M | $-345.91M | $-105.26M |
| EPS | — | — | — | — | $-4.36 |
| Free cash flow | $-101.32M | $-150.94M | $-184.46M | $-279.92M | $-81.80M |
| Profit margin | -1,328.95% | — | — | -4,612.13% | — |
Peer comparison
Smart narrative
Xenon Pharmaceuticals Inc trades at $55.75. Our Smart Value Score of 22/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 8.38, it sits in the safe zone. TTM revenue stands at $7.50M.
Frequently asked questions
What is Xenon Pharmaceuticals Inc's stock price?
Xenon Pharmaceuticals Inc (XENE) trades at $55.75.
Is Xenon Pharmaceuticals Inc overvalued?
Smart Value Score 22/100 (Grade F, Strong Sell).
What is the price target of Xenon Pharmaceuticals Inc (XENE)?
The analyst target price is $79.24, representing +42.1% upside from the current price of $55.75.
What is Xenon Pharmaceuticals Inc's revenue?
TTM revenue is $7.50M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
8.38 — safe zone.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio718.38x
ROE-51.80%
Beta0.75
50D MA$53.24
200D MA$43.02
Shares out0.10B
Float0.08B
Short ratio—
Avg volume1.5M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—